Bausch + Lomb Corp. says its 2023 results “set the tone” for its "largest" year for product launches in 2024 but the sound investors likely want to hear most is the completion of its separation from majority owner Bausch Health Companies Inc.
Bausch + Lomb Rings Bell On 'Largest' Launch Year
Canadian firm’s eye health supplements Occuvite and PreserVision remain top sellers, with ReNu and Biotrue contact lens solutions and Lumify eye drops and skin care line rounding out its top 10 revenue generators.
